The Enterprise Value as of June 2026 (TTM) for Zevra Therapeutics, Inc. (ZVRA) is 653.36M

According to Zevra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 653.36M. This represents a change of 31.74% compared to the average of 495.96M of the last 4 quarters.

Zevra Therapeutics, Inc. (ZVRA) Historical Enterprise Value (quarterly & annually)

How has ZVRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Zevra Therapeutics, Inc. over the last ten years is 195.74M. The current 653.36M Enterprise Value has changed 33.28% with respect to the historical average. Over the past ten years (40 quarters), ZVRA's Enterprise Value was at its highest in in the September 2025 quarter at 540.38M. The Enterprise Value was at its lowest in in the March 2022 quarter at 74.84M.

Zevra Therapeutics, Inc. (ZVRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zevra Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zevra Therapeutics, Inc. (ZVRA) Average Enterprise Value

How has ZVRA Enterprise Value performed in the past?

The current Enterprise Value of Zevra Therapeutics, Inc. (ZVRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zevra Therapeutics, Inc. (ZVRA) Enterprise Value vs. Peers

How is ZVRA’s Enterprise Value compared to its peers?

Zevra Therapeutics, Inc.’s Enterprise Value is less than Corvus Pharmaceuticals, Inc. (963.93M), greater than Akebia Therapeutics, Inc. (97.86M), greater than Prothena Corporation plc (110.11M), less than Olema Pharmaceuticals, Inc. (810.53M), less than Ventyx Biosciences, Inc. (982.56M), greater than Rigel Pharmaceuticals, Inc. (629.10M), greater than Niagen Bioscience Inc (210.80M), greater than REGENXBIO Inc. (400.14M), less than KalVista Pharmaceuticals, Inc. (1.49B), greater than Gossamer Bio, Inc. (199.90M),

Build a custom stock screener for Zevra Therapeutics, Inc. (ZVRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zevra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zevra Therapeutics, Inc. (ZVRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zevra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.